PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Peppermint oil - Muscle spasm

PAD Profile : Peppermint oil - Muscle spasm Important

Keywords :
smooth muscle spasm, bowel colic, stomach cramps, muscle cramps, gastro intestinal muscle cramps, gastro intestinal antispamodics, irritable bowel syndrome, IBS
Brand Names Include :
Mintec, Colpermin
Important Information :
The gastro-resistant capsules (MintecĀ®) are the most cost-effective option for Primary Care. The modified-release capsules (Colpermin) contain arachis oil - not be taken by patients with a known peanut allergy

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Formulations :
  • Capsules
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status. Mintec is 30% less costly than Colpermin in primary care (BNF Mar 2016)

Associated BNF Codes

01. Gastro-Intestinal System
01.02.00. Antispasmodics and other drugs altering gut motility
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More